Logo

Genome Canada Awards AniGenics $17.5M to Study Animal Pathogenesis

May 24, 2002

NEW YORK, May 24 - Genome Canada has awarded animal-genomics company AniGenics C$27 million, or $17.5 million, to identify host factors that influence disease resistance to certain animal-borne pathogens, the firm said today.

 

AniGenics, based in Chicago, will perform the research with a consortium that includes the Veterinary Infectious Disease Organization, the University Saskatchewan, and the University of British Columbia, according to the company.

 

Click here for more information.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.